# Mass-DAC ## expand\_more ## The Massachusetts Data Analysis Center (Mass-DAC) was a data-coordination center active 2002 through 2017, in response to a state mandate, provides expert evaluation of cardiac surgery and angioplasty data in the Commonwealth of Massachusetts. Mass-DAC collected and validated patient-specific clinical data from all Massachusetts hospitals that provide cardiac surgery or percutaneous coronary interventions. This data was used to monitor the quality of cardiac care delivered in the Commonwealth to improve the level of care provided. In appreciation for Dr. Normand's contributions as Director of Mass-DAC, she was honoured with the Outstanding Lifetime Achievement Award by the Council on Quality of Care and Outcomes Research ([QCOR](https://professional.heart.org/professional/MembershipCouncils/ScientificCouncils/UCM_320450_Council-on-Quality-of-Care-and-Outcomes-Research-QCOR.jsp)) of the American Heart Association (AHA) at the QCOR Annual Meeting in April 2017. In 2012, Dr. Normand received the Distinguished Scientist award from the American Heart Association due to her national and international leadership in the development of innovative statistical methods for health services and outcomes research. John Rumsfeld MD, PhD, former QCOR chair, said: > “Normand has demonstrated leadership in her field, and the impact of her work has been far-reaching. Her unique combination of high-level scholarship, creativity and remarkable interpersonal skills has led her work to change the way investigators approach their own research. Without question, she is considered one of the preeminent biostatisticians in the country and is certainly among the most influential individuals in health services and outcomes research.” ## Presentations 1. Normand S-L. Limitations of Analyses in Continuous Quality Improvement: Accuracy. American College of Cardiology Scientific Sessions. March 2005. 2. Stevens L. Coronary Artery Bypass Grafting after Uneventful Percutaneous Coronary Intervention in the Commonwealth of Massachusetts. American Heart Association Scientific Sessions, November 2007. 3. Shapira O. The Association of Race and of Insurance with Utilization and Outcomes after Coronary Artery Bypass Grafting Surgery in Massachusetts. American Heart Association Scientific Sessions, November 2007. 4. Mauri L. Long-Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in Massachusetts. American Heart Association Scientific Sessions, November 2007. 5. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Normand S-LT. Long-Term Clinical Outcomes Following Drug-Eluting and Bare-Metal Stenting for Acute Myocardial Infarction in Massachusetts. American College of Cardiology Scientific Sessions, March 2008. 6. Garg P, Normand S-LT, Silbaugh T, Wolf R, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L. Drug-eluting or bare metal stenting in patients with diabetes mellitus: Results from the Mass-DAC registry. American Heart Association Scientific Sessions, November 2008. 7. Sakhuja R, Silbaugh T, Varma M, Normand S-L, Mauri L. Drug-Eluting Stent Use in Acute Myocardial Infarction: Do Data Drive Practice? American College of Cardiology Scientific Sessions. March 2009. 8. Barringhaus KG, Zelevinsky K, Lovett A, Normand S-L, Ho KKL. Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2009. 9. Anis A, Normand S-L, Wolf RE, Lovett A, Mauri L, Patel N, and Jacobs AK. Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison between Hospitals with and without Cardiac Surgery On-Site. American Heart Association Scientific Sessions. November 2009. 10. Charytan DM, Varma MR, Silbaugh TS, Lovett AF, Normand S-LT, Mauri L. Long term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients with Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. American Heart Association Scientific Sessions. November 2009. 11. Khurana R. Independent US Validation of the British Columbia PCI Risk Score. American College of Cardiology Scientific Sessions. March 2010. 12. Forman DE, Vasaiwala S, Silbaugh TS, Lovett A, Normand S-L, Mauri L. Acute and 3-year Bleeding Risks: Comparing Drug-Eluting to Bare-Metal Stents in Old and Very Old Adults in a Community Population. American Heart Association Scientific Sessions. November 2010. 13. Yeh RW, Zelevinsky K, Normand S-LT, Sakhuja R, Lovett A, Weiner BH, Rosenfield KA. 30-Day All-Cause Readmission After Percutaneous Coronary Intervention in Massachusetts: Clinical Predictors and Hospital-Variation of a New Quality Metric. American Heart Association Scientific Sessions. November 2010. 14. Ali MJ, Nedeljkovic ZS, Zelevinsky K, Lovett A, Normand S-LT, Jacobs AK. Mortality in STEMI Patients Undergoing Inter-Hospital Transfer for Primary PCI in Massachusetts. American Heart Association Scientific Sessions. November 2010. 15. Albert MA, Silbaugh TS, Ayanian JZ, Lovett A, Wolf RE, Zelevinsky K, Resnic F, Normand S-LT. Impact of Massachusetts Health Care Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care. American Heart Association Scientific Sessions. November 2010. 16. Normand S-LT, Treacy S. Silbaugh, Zelevinsky K, Wolf RE, Cioffi M, Lovett A, Resnic FS, Ho KKL. Hospital Quality Following Percutaneous Coronary Intervention: Massachusetts Experience From 2003-2007. American Heart Association Scientific Sessions. November 2010. 17. Kato NS, Cioffi M, Normand S-LT. Implantable Cardioverter Defibrillator Usage in the Commonwealth of Massachusetts – A 10 Year Study. American Heart Association Scientific Sessions. November 2010. 18. Kato NS, Cioffi M, Normand S-LT. Unsupported Implantable Cardioverter Defibrillator Use in the Commonwealth of Massachusetts - 1997 to 2008. American Heart Association Scientific Sessions. November 2010. 19. Cubeddu RJ, Lago RM, Zelevinsky K, Lovett AF, Mendoza I, Crane AM, Witzke CF, Normand S-LT, Pomerantsev E, Palacios IF. No Mortality Advantage of “On” versus “Off”-hours Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Results from the Massachusetts Data Analysis Center Registry. American Heart Association Scientific Sessions. November 2010. 20. Normand S-LT, Silbaugh TS, Zelevinsky K, Wolf RE, Cioffi M, Lovett A, Resnic FS, Ho KKL. Hospital-quality Following Percutaneous Coronary Intervention: Massachusetts Experience From 2003-2007. American College of Cardiology Scientific Sessions. May 2010. 21. Anis A, Normand S-LT, Wolf RE, Lovett A, Mauri L, Patel N, and Jacobs AK. Primary Percutaneous Coronary Intervention With or Without Cardiac Surgery On-Site: Massachusetts’ Experience. American Heart Association Scientific Sessions. November 2010. 22. Yeh RW, Jones PG, Wolf RE, Normand S-LT, Cohen DJ, Ho KKL, Cutlip DE, Kugelmass AD, Spertus JA. Predicting the Restenosis Benefit of Drug-Eluting vs. Bare Metal Stenting Prior to Angiography: A Tool for Patients and Clinicians. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2010. 23. Kato NS, Cioffi M, Normand S-LT. Internal Cardioverter Defibrillator Utilization in the Commonwealth of Massachusetts - 1997 to 2008. American College of Cardiology Scientific Sessions. March 2011. 24. Vasaiwala S, Normand S-LT, Silbaugh TS, Forman D, Baron S, Lovett A, Mauri L. Impact of Completeness of Revascularization on Late Mortality in an Unrestricted Patient Population Undergoing Percutaneous Coronary Intervention with Drug-Eluting or Bare-Metal Stents. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2011. 25. Forman D, Vasaiwala S, Silbaugh TS, Lovett A, Normand S-LT, Mauri L. Assessing utility of drug-eluting stents in coronary patients aged 85 years and older. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2011. 26. Yeh RW, Normand S-LT, Mauri L, Wolf RE, Cohen DJ, Ho KKL, Spertus JA. Does the Expected Reduction in Restenosis from Drug-Eluting Stents Predict Actual Use? An Assessment of Treatment-Risk Paradox Using the C-statistic. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2011. 27. Vasaiwala S, Forman D, Yeh RW, Silbaugh TS, Lovett A, Normand S-LT, and Mauri L. Selective Drug-Eluting Stent Use in Elderly Patients: Impact on Percutaneous Coronary Intervention Mortality and Bleeding Risk. American College of Cardiology Scientific Sessions. March 2012. 28. Cubeddu R, Lago R, Zelevinsky K, Lovett A, Mendoza I, Crane A, Witzke C, Normand S-L, Pomerantsez E, Palacio I. No Mortality Advantage of “On” versus “Off”-hours Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Results from the Massachusetts Data Analysis Center Registry. 29. Sarma A, Normand S-LT, Hatfield L, Matheny M, Resnic F. The Learning Curve for Medical Devices: Experience with Vascular Closure Devices in Massachusetts. American College of Cardiology Scientific Sessions. March 2013. American Heart Association Scientific Sessions. November 2012. 30. Yeh RW, Mauri L, Wold R, Romm I, Lovett A, Normand S-L. Steep Declines in Population Rates of Coronary Revascularization. American Heart Association Scientific Sessions. November 2013. 31. Yeh RW, Mauri L, Wolf RE, Romm IK, Biondolillo M, Lovett A, Normand S-LT. Steep Declines in Population Rates of Coronary Revascularization. American College of Cardiology Scientific Sessions. March 2014. 32. Adhikari S, Normand S-L T. Non-parametric Bayesian Instrumental Variable Analysis: Comparing effectiveness of radial vs femoral arteries access Percutaneous Coronary Intervention (PCI) in reducing bleeding and vascular complications. EMR-IBS and Italian Region Conference. May 2017. ## Publications Download 34 citations download- [BibTeX](/bibcite/export?pager_style=no_pager&number_of_items=36&sort_field=bibcite_year--desc&&content_filter%5B0%5D=573416&content_filter%5B1%5D=573541&content_filter%5B2%5D=722111&content_filter%5B3%5D=573296&content_filter%5B4%5D=573311&content_filter%5B5%5D=573276&content_filter%5B6%5D=573246&content_filter%5B7%5D=573256&content_filter%5B8%5D=573226&content_filter%5B9%5D=573206&content_filter%5B10%5D=573166&content_filter%5B11%5D=516606&content_filter%5B12%5D=516616&content_filter%5B13%5D=516601&content_filter%5B14%5D=516521&content_filter%5B15%5D=516446&content_filter%5B16%5D=516456&content_filter%5B17%5D=516401&content_filter%5B18%5D=516391&content_filter%5B19%5D=516406&content_filter%5B20%5D=516431&content_filter%5B21%5D=516301&content_filter%5B22%5D=516296&content_filter%5B23%5D=516291&content_filter%5B24%5D=516316&content_filter%5B25%5D=516241&content_filter%5B26%5D=516266&content_filter%5B27%5D=516211&content_filter%5B28%5D=516071&content_filter%5B29%5D=516151&content_filter%5B30%5D=722101&content_filter%5B31%5D=722116&content_filter%5B32%5D=722121&content_filter%5B33%5D=722126&&format=bibtex) - [EndNote X3 XML](/bibcite/export?pager_style=no_pager&number_of_items=36&sort_field=bibcite_year--desc&&content_filter%5B0%5D=573416&content_filter%5B1%5D=573541&content_filter%5B2%5D=722111&content_filter%5B3%5D=573296&content_filter%5B4%5D=573311&content_filter%5B5%5D=573276&content_filter%5B6%5D=573246&content_filter%5B7%5D=573256&content_filter%5B8%5D=573226&content_filter%5B9%5D=573206&content_filter%5B10%5D=573166&content_filter%5B11%5D=516606&content_filter%5B12%5D=516616&content_filter%5B13%5D=516601&content_filter%5B14%5D=516521&content_filter%5B15%5D=516446&content_filter%5B16%5D=516456&content_filter%5B17%5D=516401&content_filter%5B18%5D=516391&content_filter%5B19%5D=516406&content_filter%5B20%5D=516431&content_filter%5B21%5D=516301&content_filter%5B22%5D=516296&content_filter%5B23%5D=516291&content_filter%5B24%5D=516316&content_filter%5B25%5D=516241&content_filter%5B26%5D=516266&content_filter%5B27%5D=516211&content_filter%5B28%5D=516071&content_filter%5B29%5D=516151&content_filter%5B30%5D=722101&content_filter%5B31%5D=722116&content_filter%5B32%5D=722121&content_filter%5B33%5D=722126&&format=endnote8) - [EndNote 7 XML](/bibcite/export?pager_style=no_pager&number_of_items=36&sort_field=bibcite_year--desc&&content_filter%5B0%5D=573416&content_filter%5B1%5D=573541&content_filter%5B2%5D=722111&content_filter%5B3%5D=573296&content_filter%5B4%5D=573311&content_filter%5B5%5D=573276&content_filter%5B6%5D=573246&content_filter%5B7%5D=573256&content_filter%5B8%5D=573226&content_filter%5B9%5D=573206&content_filter%5B10%5D=573166&content_filter%5B11%5D=516606&content_filter%5B12%5D=516616&content_filter%5B13%5D=516601&content_filter%5B14%5D=516521&content_filter%5B15%5D=516446&content_filter%5B16%5D=516456&content_filter%5B17%5D=516401&content_filter%5B18%5D=516391&content_filter%5B19%5D=516406&content_filter%5B20%5D=516431&content_filter%5B21%5D=516301&content_filter%5B22%5D=516296&content_filter%5B23%5D=516291&content_filter%5B24%5D=516316&content_filter%5B25%5D=516241&content_filter%5B26%5D=516266&content_filter%5B27%5D=516211&content_filter%5B28%5D=516071&content_filter%5B29%5D=516151&content_filter%5B30%5D=722101&content_filter%5B31%5D=722116&content_filter%5B32%5D=722121&content_filter%5B33%5D=722126&&format=endnote7) - [Endnote tagged](/bibcite/export?pager_style=no_pager&number_of_items=36&sort_field=bibcite_year--desc&&content_filter%5B0%5D=573416&content_filter%5B1%5D=573541&content_filter%5B2%5D=722111&content_filter%5B3%5D=573296&content_filter%5B4%5D=573311&content_filter%5B5%5D=573276&content_filter%5B6%5D=573246&content_filter%5B7%5D=573256&content_filter%5B8%5D=573226&content_filter%5B9%5D=573206&content_filter%5B10%5D=573166&content_filter%5B11%5D=516606&content_filter%5B12%5D=516616&content_filter%5B13%5D=516601&content_filter%5B14%5D=516521&content_filter%5B15%5D=516446&content_filter%5B16%5D=516456&content_filter%5B17%5D=516401&content_filter%5B18%5D=516391&content_filter%5B19%5D=516406&content_filter%5B20%5D=516431&content_filter%5B21%5D=516301&content_filter%5B22%5D=516296&content_filter%5B23%5D=516291&content_filter%5B24%5D=516316&content_filter%5B25%5D=516241&content_filter%5B26%5D=516266&content_filter%5B27%5D=516211&content_filter%5B28%5D=516071&content_filter%5B29%5D=516151&content_filter%5B30%5D=722101&content_filter%5B31%5D=722116&content_filter%5B32%5D=722121&content_filter%5B33%5D=722126&&format=tagged) - [Marc](/bibcite/export?pager_style=no_pager&number_of_items=36&sort_field=bibcite_year--desc&&content_filter%5B0%5D=573416&content_filter%5B1%5D=573541&content_filter%5B2%5D=722111&content_filter%5B3%5D=573296&content_filter%5B4%5D=573311&content_filter%5B5%5D=573276&content_filter%5B6%5D=573246&content_filter%5B7%5D=573256&content_filter%5B8%5D=573226&content_filter%5B9%5D=573206&content_filter%5B10%5D=573166&content_filter%5B11%5D=516606&content_filter%5B12%5D=516616&content_filter%5B13%5D=516601&content_filter%5B14%5D=516521&content_filter%5B15%5D=516446&content_filter%5B16%5D=516456&content_filter%5B17%5D=516401&content_filter%5B18%5D=516391&content_filter%5B19%5D=516406&content_filter%5B20%5D=516431&content_filter%5B21%5D=516301&content_filter%5B22%5D=516296&content_filter%5B23%5D=516291&content_filter%5B24%5D=516316&content_filter%5B25%5D=516241&content_filter%5B26%5D=516266&content_filter%5B27%5D=516211&content_filter%5B28%5D=516071&content_filter%5B29%5D=516151&content_filter%5B30%5D=722101&content_filter%5B31%5D=722116&content_filter%5B32%5D=722121&content_filter%5B33%5D=722126&&format=marc) - [PubMedId](/bibcite/export?pager_style=no_pager&number_of_items=36&sort_field=bibcite_year--desc&&content_filter%5B0%5D=573416&content_filter%5B1%5D=573541&content_filter%5B2%5D=722111&content_filter%5B3%5D=573296&content_filter%5B4%5D=573311&content_filter%5B5%5D=573276&content_filter%5B6%5D=573246&content_filter%5B7%5D=573256&content_filter%5B8%5D=573226&content_filter%5B9%5D=573206&content_filter%5B10%5D=573166&content_filter%5B11%5D=516606&content_filter%5B12%5D=516616&content_filter%5B13%5D=516601&content_filter%5B14%5D=516521&content_filter%5B15%5D=516446&content_filter%5B16%5D=516456&content_filter%5B17%5D=516401&content_filter%5B18%5D=516391&content_filter%5B19%5D=516406&content_filter%5B20%5D=516431&content_filter%5B21%5D=516301&content_filter%5B22%5D=516296&content_filter%5B23%5D=516291&content_filter%5B24%5D=516316&content_filter%5B25%5D=516241&content_filter%5B26%5D=516266&content_filter%5B27%5D=516211&content_filter%5B28%5D=516071&content_filter%5B29%5D=516151&content_filter%5B30%5D=722101&content_filter%5B31%5D=722116&content_filter%5B32%5D=722121&content_filter%5B33%5D=722126&&format=pubmed_id) - [RIS](/bibcite/export?pager_style=no_pager&number_of_items=36&sort_field=bibcite_year--desc&&content_filter%5B0%5D=573416&content_filter%5B1%5D=573541&content_filter%5B2%5D=722111&content_filter%5B3%5D=573296&content_filter%5B4%5D=573311&content_filter%5B5%5D=573276&content_filter%5B6%5D=573246&content_filter%5B7%5D=573256&content_filter%5B8%5D=573226&content_filter%5B9%5D=573206&content_filter%5B10%5D=573166&content_filter%5B11%5D=516606&content_filter%5B12%5D=516616&content_filter%5B13%5D=516601&content_filter%5B14%5D=516521&content_filter%5B15%5D=516446&content_filter%5B16%5D=516456&content_filter%5B17%5D=516401&content_filter%5B18%5D=516391&content_filter%5B19%5D=516406&content_filter%5B20%5D=516431&content_filter%5B21%5D=516301&content_filter%5B22%5D=516296&content_filter%5B23%5D=516291&content_filter%5B24%5D=516316&content_filter%5B25%5D=516241&content_filter%5B26%5D=516266&content_filter%5B27%5D=516211&content_filter%5B28%5D=516071&content_filter%5B29%5D=516151&content_filter%5B30%5D=722101&content_filter%5B31%5D=722116&content_filter%5B32%5D=722121&content_filter%5B33%5D=722126&&format=ris) ### 2007 David Shahian, Treacy Silverstein, Ann Lovett, Robert Wolf, and Sharon-Lise Normand. 2007. “[Comparison of Clinical and Administrative Data Sources for Hospital Coronary Artery Bypass Graft Surgery Report Cards](/publications/comparison-clinical-and-administrative-data-sources-hospital-coronary-artery)”. Circulation, 115, 12, Pp. 1518-27. doi:10.1161/CIRCULATIONAHA.106.633008 David Shahian, Treacy Silverstein, Ann Lovett, Robert Wolf, and Sharon-Lise Normand. 2007. “[Comparison of Clinical and Administrative Data Sources for Hospital Coronary Artery Bypass Graft Surgery Report Cards](/publications/comparison-clinical-and-administrative-data-sources-hospital-coronary-artery)”. Circulation, 115, 12, Pp. 1518-27. doi:10.1161/CIRCULATIONAHA.106.633008 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Regardless of statistical methodology, public performance report cards must use the highest-quality validated data, preferably from a prospectively maintained clinical database. Using logistic regression and hierarchical models, we compared... Sharon-Lise T. Normand and David M. Shahian. 2007. “[Statistical and Clinical Aspects of Hospital Outcomes Profiling](/publication/statistical-and-clinical-aspects-hospital-outcomes-profiling)”. Statistical Science, 22, Pp. 206–226 Sharon-Lise T. Normand and David M. Shahian. 2007. “[Statistical and Clinical Aspects of Hospital Outcomes Profiling](/publication/statistical-and-clinical-aspects-hospital-outcomes-profiling)”. Statistical Science, 22, Pp. 206–226 - add\_circle do\_not\_disturb\_on Abstract Hospital profiling involves a comparison of a health care provider s structure, processes of care, or outcomes to a standard, often in the form of a report card. Given the ubiquity of report cards and similar consumer ratings in contemporary American... ### 2005 David Shahian, David Torchiana, Richard Shemin, James Rawn, and Sharon-Lise Normand. 2005. “[Massachusetts Cardiac Surgery Report Card: Implications of Statistical Methodology](/publications/massachusetts-cardiac-surgery-report-card-implications-statistical-methodology)”. Ann Thorac Surg, 80, 6, Pp. 2106-13. doi:10.1016/j.athoracsur.2005.06.078 David Shahian, David Torchiana, Richard Shemin, James Rawn, and Sharon-Lise Normand. 2005. “[Massachusetts Cardiac Surgery Report Card: Implications of Statistical Methodology](/publications/massachusetts-cardiac-surgery-report-card-implications-statistical-methodology)”. Ann Thorac Surg, 80, 6, Pp. 2106-13. doi:10.1016/j.athoracsur.2005.06.078 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Choice of statistical methodology may significantly impact the results of provider profiling, including cardiac surgery report cards. Because of sample size and clustering issues, logistic regression may overestimate systematic interprovider... David M Shahian, David F Torchiana, and Sharon-Lise T Normand. 2005. “[Implementation of a Cardiac Surgery Report Card: Lessons from the Massachusetts Experience.](/publication/implementation-cardiac-surgery-report-card-lessons-massachusetts-experience)”. The Annals of Thoracic Surgery, 80, 3, Pp. 1146-50 David M Shahian, David F Torchiana, and Sharon-Lise T Normand. 2005. “[Implementation of a Cardiac Surgery Report Card: Lessons from the Massachusetts Experience.](/publication/implementation-cardiac-surgery-report-card-lessons-massachusetts-experience)”. The Annals of Thoracic Surgery, 80, 3, Pp. 1146-50 - add\_circle do\_not\_disturb\_on Abstract Demand is increasing for public accountability in health care. In 2000, the Massachusetts legislature mandated a state report card for cardiac surgery and percutaneous coronary interventions. During the planning and implementation of this report card, a... ### 2008 Justin Timbie, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2008. “[A Cost-Effectiveness Framework for Profiling the Value of Hospital Care](/publications/cost-effectiveness-framework-profiling-value-hospital-care)”. Med Decis Making, 28, 3, Pp. 419-34. doi:10.1177/0272989X07312476 Justin Timbie, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2008. “[A Cost-Effectiveness Framework for Profiling the Value of Hospital Care](/publications/cost-effectiveness-framework-profiling-value-hospital-care)”. Med Decis Making, 28, 3, Pp. 419-34. doi:10.1177/0272989X07312476 - add\_circle do\_not\_disturb\_on Abstract Provider profiling and performance-based incentive programs have expanded in recent years but need a theoretical framework for measuring and comparing the "value'' of clinical care across medical providers. Cost-effectiveness analysis provides such a... David Shahian and Sharon-Lise Normand. 2008. “[Comparison of ‘risk-Adjusted’ Hospital Outcomes](/publications/comparison-risk-adjusted-hospital-outcomes)”. Circulation, 117, 15, Pp. 1955-63. doi:10.1161/CIRCULATIONAHA.107.747873 David Shahian and Sharon-Lise Normand. 2008. “[Comparison of ‘risk-Adjusted’ Hospital Outcomes](/publications/comparison-risk-adjusted-hospital-outcomes)”. Circulation, 117, 15, Pp. 1955-63. doi:10.1161/CIRCULATIONAHA.107.747873 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: A frequent challenge in outcomes research is the comparison of rates from different populations. One common example with substantial health policy implications involves the determination and comparison of hospital outcomes. The concept of... Sharon-Lise Normand. 2008. “[Some Old and Some New Statistical Tools for Outcomes Research](/publications/some-old-and-some-new-statistical-tools-outcomes-research)”. Circulation, 118, 8, Pp. 872-84. doi:10.1161/CIRCULATIONAHA.108.766907 Sharon-Lise Normand. 2008. “[Some Old and Some New Statistical Tools for Outcomes Research](/publications/some-old-and-some-new-statistical-tools-outcomes-research)”. Circulation, 118, 8, Pp. 872-84. doi:10.1161/CIRCULATIONAHA.108.766907 Laura Mauri, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Zheng Zhou, Frederic Resnic, and Sharon-Lise Normand. 2008. “[Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts](/publications/long-term-clinical-outcomes-after-drug-eluting-and-bare-metal-stenting)”. Circulation, 118, 18, Pp. 1817-27. doi:10.1161/CIRCULATIONAHA.108.781377 Laura Mauri, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Zheng Zhou, Frederic Resnic, and Sharon-Lise Normand. 2008. “[Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts](/publications/long-term-clinical-outcomes-after-drug-eluting-and-bare-metal-stenting)”. Circulation, 118, 18, Pp. 1817-27. doi:10.1161/CIRCULATIONAHA.108.781377 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Drug-eluting stents (DES) reduce the need for repeat revascularization, but their long-term safety relative to that of bare-metal stents (BMS) in general use remains uncertain. We sought to compare the clinical outcome of patients treated with... Laura Mauri, Treacy Silbaugh, Pallav Garg, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Sharon-Lise Normand. 2008. “[Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction](/publications/drug-eluting-or-bare-metal-stents-acute-myocardial-infarction)”. N Engl J Med, 359, 13, Pp. 1330-42. doi:10.1056/NEJMoa0801485 Laura Mauri, Treacy Silbaugh, Pallav Garg, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Sharon-Lise Normand. 2008. “[Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction](/publications/drug-eluting-or-bare-metal-stents-acute-myocardial-infarction)”. N Engl J Med, 359, 13, Pp. 1330-42. doi:10.1056/NEJMoa0801485 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Studies comparing percutaneous coronary intervention (PCI) with drug-eluting and bare-metal coronary stents in acute myocardial infarction have been limited in size and duration.METHODS: We identified all adults undergoing PCI with stenting... Pallav Garg, Sharon-Lise Normand, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Laura Mauri. 2008. “[Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results from the Massachusetts Data Analysis Center Registry](/publications/drug-eluting-or-bare-metal-stenting-patients-diabetes-mellitus-results)”. Circulation, 118, 22, Pp. 2277-85, 7p following 2285. doi:10.1161/CIRCULATIONAHA.108.820159 Pallav Garg, Sharon-Lise Normand, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Laura Mauri. 2008. “[Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results from the Massachusetts Data Analysis Center Registry](/publications/drug-eluting-or-bare-metal-stenting-patients-diabetes-mellitus-results)”. Circulation, 118, 22, Pp. 2277-85, 7p following 2285. doi:10.1161/CIRCULATIONAHA.108.820159 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Patients with diabetes mellitus (DM) are at high risk for restenosis, myocardial infarction, and cardiac mortality after coronary stenting, and the long-term safety of drug-eluting stents (DES) relative to bare-metal stents (BMS) in DM is... ### 2009 Justin Timbie, David Shahian, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2009. “[Composite Measures for Hospital Quality Using Quality-Adjusted Life Years](/publications/composite-measures-hospital-quality-using-quality-adjusted-life-years)”. Stat Med, 28, 8, Pp. 1238-54. doi:10.1002/sim.3539 Justin Timbie, David Shahian, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2009. “[Composite Measures for Hospital Quality Using Quality-Adjusted Life Years](/publications/composite-measures-hospital-quality-using-quality-adjusted-life-years)”. Stat Med, 28, 8, Pp. 1238-54. doi:10.1002/sim.3539 - add\_circle do\_not\_disturb\_on Abstract Developing clinically meaningful summary measures of health-care quality is key to inferring quality of care. Current summary measures use a number of different approaches to weight their individual measures but rarely use weights based on clinical... Luis Castellanos, Sharon-Lise Normand, and John Ayanian. 2009. “[Racial and Ethnic Disparities in Access to Higher and Lower Quality Cardiac Surgeons for Coronary Artery Bypass Grafting](/publications/racial-and-ethnic-disparities-access-higher-and-lower-quality-cardiac-surgeons)”. Am J Cardiol, 103, 12, Pp. 1682-6. doi:10.1016/j.amjcard.2009.02.019 Luis Castellanos, Sharon-Lise Normand, and John Ayanian. 2009. “[Racial and Ethnic Disparities in Access to Higher and Lower Quality Cardiac Surgeons for Coronary Artery Bypass Grafting](/publications/racial-and-ethnic-disparities-access-higher-and-lower-quality-cardiac-surgeons)”. Am J Cardiol, 103, 12, Pp. 1682-6. doi:10.1016/j.amjcard.2009.02.019 - add\_circle do\_not\_disturb\_on Abstract To determine whether Hispanic and African-American patients are treated by cardiac surgeons with better or worse risk-standardized outcomes than surgeons of white patients, clinical data from the Massachusetts Data Analysis Center Registry were analyzed... ### 2011 David Charytan, Manu Varma, Treacy Silbaugh, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2011. “[Long-Term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry](/publications/long-term-clinical-outcomes-following-drug-eluting-or-bare-metal-stent)”. Am J Kidney Dis, 57, 2, Pp. 202-11. doi:10.1053/j.ajkd.2010.09.017 David Charytan, Manu Varma, Treacy Silbaugh, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2011. “[Long-Term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry](/publications/long-term-clinical-outcomes-following-drug-eluting-or-bare-metal-stent)”. Am J Kidney Dis, 57, 2, Pp. 202-11. doi:10.1053/j.ajkd.2010.09.017 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Patients with chronic kidney disease have been under-represented in randomized trials of drug-eluting stents relative to bare-metal stents and are at high risk of mortality.STUDY DESIGN: Cohort study with propensity score matching.SETTINGS &... Kurt Barringhaus, Katya Zelevinsky, Ann Lovett, Sharon-Lise Normand, and Kalon Ho. 2011. “[Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts](/publications/impact-independent-data-adjudication-hospital-specific-estimates-risk-adjusted)”. Circ Cardiovasc Qual Outcomes, 4, 1, Pp. 92-8. doi:10.1161/CIRCOUTCOMES.110.957597 Kurt Barringhaus, Katya Zelevinsky, Ann Lovett, Sharon-Lise Normand, and Kalon Ho. 2011. “[Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts](/publications/impact-independent-data-adjudication-hospital-specific-estimates-risk-adjusted)”. Circ Cardiovasc Qual Outcomes, 4, 1, Pp. 92-8. doi:10.1161/CIRCOUTCOMES.110.957597 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: As part of state-mandated public reporting of outcomes after percutaneous coronary interventions (PCIs) in Massachusetts, procedural and clinical data were prospectively collected. Variables associated with higher mortality were audited to... Frederic Resnic, Sharon-Lise Normand, Thomas Piemonte, Samuel Shubrooks, Katya Zelevinsky, Ann Lovett, and Kalon Ho. 2011. “[Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention through the Addition of a ‘compassionate Use’ Variable to the National Cardiovascular Data Registry CathPCI Dataset: A Study from the Massachusetts Angioplasty Registry](/publications/improvement-mortality-risk-prediction-after-percutaneous-coronary-intervention)”. J Am Coll Cardiol, 57, 8, Pp. 904-11. doi:10.1016/j.jacc.2010.09.057 Frederic Resnic, Sharon-Lise Normand, Thomas Piemonte, Samuel Shubrooks, Katya Zelevinsky, Ann Lovett, and Kalon Ho. 2011. “[Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention through the Addition of a ‘compassionate Use’ Variable to the National Cardiovascular Data Registry CathPCI Dataset: A Study from the Massachusetts Angioplasty Registry](/publications/improvement-mortality-risk-prediction-after-percutaneous-coronary-intervention)”. J Am Coll Cardiol, 57, 8, Pp. 904-11. doi:10.1016/j.jacc.2010.09.057 - add\_circle do\_not\_disturb\_on Abstract OBJECTIVES: This study investigated the impact of adding novel elements to models predicting in-hospital mortality after percutaneous coronary interventions (PCIs).BACKGROUND: Massachusetts mandated public reporting of hospital-specific PCI mortality in... Robert Yeh, Sharon-Lise Normand, Robert Wolf, Philip Jones, Kalon Ho, David Cohen, Donald Cutlip, Laura Mauri, Aaron Kugelmass, Amit Amin, and John Spertus. 2011. “[Predicting the Restenosis Benefit of Drug-Eluting versus Bare Metal Stents in Percutaneous Coronary Intervention](/publications/predicting-restenosis-benefit-drug-eluting-versus-bare-metal-stents)”. Circulation, 124, 14, Pp. 1557-64. doi:10.1161/CIRCULATIONAHA.111.045229 Robert Yeh, Sharon-Lise Normand, Robert Wolf, Philip Jones, Kalon Ho, David Cohen, Donald Cutlip, Laura Mauri, Aaron Kugelmass, Amit Amin, and John Spertus. 2011. “[Predicting the Restenosis Benefit of Drug-Eluting versus Bare Metal Stents in Percutaneous Coronary Intervention](/publications/predicting-restenosis-benefit-drug-eluting-versus-bare-metal-stents)”. Circulation, 124, 14, Pp. 1557-64. doi:10.1161/CIRCULATIONAHA.111.045229 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Drug-eluting stents (DES) for percutaneous coronary intervention decrease the risk of restenosis compared with bare metal stents. However, they are costlier, require prolonged dual antiplatelet therapy, and provide the most benefit in patients... ### 2012 David Shahian, Lisa Iezzoni, Gregg Meyer, Leslie Kirle, and Sharon-Lise Normand. 2012. “[Hospital-Wide Mortality As a Quality Metric: Conceptual and Methodological Challenges](/publications/hospital-wide-mortality-quality-metric-conceptual-and-methodological-challenges)”. Am J Med Qual, 27, 2, Pp. 112-23. doi:10.1177/1062860611412358 David Shahian, Lisa Iezzoni, Gregg Meyer, Leslie Kirle, and Sharon-Lise Normand. 2012. “[Hospital-Wide Mortality As a Quality Metric: Conceptual and Methodological Challenges](/publications/hospital-wide-mortality-quality-metric-conceptual-and-methodological-challenges)”. Am J Med Qual, 27, 2, Pp. 112-23. doi:10.1177/1062860611412358 - add\_circle do\_not\_disturb\_on Abstract Hospital-wide mortality rates are used as a measure of overall hospital quality. However, their parsimony and apparent simplicity belie significant conceptual and methodological concerns. For many diagnoses included in hospital-wide mortality, the... Robert Yeh, Sharon-Lise Normand, Yun Wang, Christopher Barr, and Francesca Dominici. 2012. “[Geographic Disparities in the Incidence and Outcomes of Hospitalized Myocardial Infarction: Does a Rising Tide Lift All Boats?](/publications/geographic-disparities-incidence-and-outcomes-hospitalized-myocardial)”. Circ Cardiovasc Qual Outcomes, 5, 2, Pp. 197-204. doi:10.1161/CIRCOUTCOMES.111.962456 Robert Yeh, Sharon-Lise Normand, Yun Wang, Christopher Barr, and Francesca Dominici. 2012. “[Geographic Disparities in the Incidence and Outcomes of Hospitalized Myocardial Infarction: Does a Rising Tide Lift All Boats?](/publications/geographic-disparities-incidence-and-outcomes-hospitalized-myocardial)”. Circ Cardiovasc Qual Outcomes, 5, 2, Pp. 197-204. doi:10.1161/CIRCOUTCOMES.111.962456 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Improvements in prevention have led to declines in incidence and mortality of myocardial infarction (MI) in selected populations. However, no studies have examined regional differences in recent trends in MI incidence, and few have examined... Sotiris Stamou, Michael Robich, Robert Wolf, Ann Lovett, Sharon-Lise Normand, and Frank Sellke. 2012. “[Effects of Gender and Ethnicity on Outcomes After Aortic Valve Replacement](/publications/effects-gender-and-ethnicity-outcomes-after-aortic-valve-replacement)”. J Thorac Cardiovasc Surg, 144, 2, Pp. 486-92. doi:10.1016/j.jtcvs.2011.11.023 Sotiris Stamou, Michael Robich, Robert Wolf, Ann Lovett, Sharon-Lise Normand, and Frank Sellke. 2012. “[Effects of Gender and Ethnicity on Outcomes After Aortic Valve Replacement](/publications/effects-gender-and-ethnicity-outcomes-after-aortic-valve-replacement)”. J Thorac Cardiovasc Surg, 144, 2, Pp. 486-92. doi:10.1016/j.jtcvs.2011.11.023 - add\_circle do\_not\_disturb\_on Abstract OBJECTIVE: To evaluate the clinical outcomes after aortic valve replacement or aortic valve replacement and coronary artery bypass grafting in a large contemporary population, and to determine if outcomes are associated with patient ethnicity and gender... Amit Amin, John Spertus, David Cohen, Adnan Chhatriwalla, Kevin Kennedy, Katherine Vilain, Adam Salisbury, Lakshmi Venkitachalam, Sue Min Lai, Laura Mauri, Sharon-Lise Normand, John Rumsfeld, John Messenger, and Robert Yeh. 2012. “[Use of Drug-Eluting Stents As a Function of Predicted Benefit: Clinical and Economic Implications of Current Practice](/publications/use-drug-eluting-stents-function-predicted-benefit-clinical-and-economic)”. Arch Intern Med, 172, 15, Pp. 1145-52. doi:10.1001/archinternmed.2012.3093 Amit Amin, John Spertus, David Cohen, Adnan Chhatriwalla, Kevin Kennedy, Katherine Vilain, Adam Salisbury, Lakshmi Venkitachalam, Sue Min Lai, Laura Mauri, Sharon-Lise Normand, John Rumsfeld, John Messenger, and Robert Yeh. 2012. “[Use of Drug-Eluting Stents As a Function of Predicted Benefit: Clinical and Economic Implications of Current Practice](/publications/use-drug-eluting-stents-function-predicted-benefit-clinical-and-economic)”. Arch Intern Med, 172, 15, Pp. 1145-52. doi:10.1001/archinternmed.2012.3093 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Benefits of drug-eluting stents (DES) in percutaneous coronary intervention (PCI) are greatest in those at the highest risk of target-vessel revascularization (TVR). Drug-eluting stents cost more than bare-metal stents (BMS) and necessitate... Venkatesan Vidi, Michael Matheny, Usha Govindarajulu, Sharon-Lise Normand, Susan Robbins, Vikram Agarwal, Sripal Bangalore, and Frederic Resnic. 2012. “[Vascular Closure Device Failure in Contemporary Practice](/publications/vascular-closure-device-failure-contemporary-practice)”. JACC Cardiovasc Interv, 5, 8, Pp. 837-44. doi:10.1016/j.jcin.2012.05.005 Venkatesan Vidi, Michael Matheny, Usha Govindarajulu, Sharon-Lise Normand, Susan Robbins, Vikram Agarwal, Sripal Bangalore, and Frederic Resnic. 2012. “[Vascular Closure Device Failure in Contemporary Practice](/publications/vascular-closure-device-failure-contemporary-practice)”. JACC Cardiovasc Interv, 5, 8, Pp. 837-44. doi:10.1016/j.jcin.2012.05.005 - add\_circle do\_not\_disturb\_on Abstract OBJECTIVES: The goal of this study was to assess the frequency and predictors of vascular closure device (VCD) deployment failure, and its association with vascular complications of 3 commonly used VCDs.BACKGROUND: VCDs are commonly used following... Robert Yeh, Kenneth Rosenfield, Katya Zelevinsky, Laura Mauri, Rahul Sakhuja, Daniel Shivapour, Ann Lovett, Bonnie Weiner, Alice Jacobs, and Sharon-Lise Normand. 2012. “[Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention](/publications/sources-hospital-variation-short-term-readmission-rates-after-percutaneous)”. Circ Cardiovasc Interv, 5, 2, Pp. 227-36. doi:10.1161/CIRCINTERVENTIONS.111.967638 Robert Yeh, Kenneth Rosenfield, Katya Zelevinsky, Laura Mauri, Rahul Sakhuja, Daniel Shivapour, Ann Lovett, Bonnie Weiner, Alice Jacobs, and Sharon-Lise Normand. 2012. “[Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention](/publications/sources-hospital-variation-short-term-readmission-rates-after-percutaneous)”. Circ Cardiovasc Interv, 5, 2, Pp. 227-36. doi:10.1161/CIRCINTERVENTIONS.111.967638 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Risk-standardized all-cause 30-day readmission rates (RSRRs) after percutaneous coronary intervention (PCI) have been endorsed as a national measure of hospital quality. Little is known about variation in the performance of hospitals on this... ### 2013 John Bittl, Yulei He, Alice Jacobs, Clyde Yancy, and Sharon-Lise Normand. 2013. “[Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease](/publications/bayesian-methods-affirm-use-percutaneous-coronary-intervention-improve-survival)”. Circulation, 127, 22, Pp. 2177-85. doi:10.1161/CIRCULATIONAHA.112.000646 John Bittl, Yulei He, Alice Jacobs, Clyde Yancy, and Sharon-Lise Normand. 2013. “[Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease](/publications/bayesian-methods-affirm-use-percutaneous-coronary-intervention-improve-survival)”. Circulation, 127, 22, Pp. 2177-85. doi:10.1161/CIRCULATIONAHA.112.000646 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Several randomized clinical trials support the use of coronary artery bypass grafting (CABG) for patients with unprotected left main coronary artery disease. Studies suggesting the equivalence of percutaneous coronary intervention (PCI) with... Daniel Kramer, Kevin Kennedy, Peter Noseworthy, Alfred Buxton, Mark Josephson, Sharon-Lise Normand, John Spertus, Peter Zimetbaum, Matthew Reynolds, and Susan Mitchell. 2013. “[Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results from the NCDR](/publications/characteristics-and-outcomes-patients-receiving-new-and-replacement-implantable)”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 488-97. doi:10.1161/CIRCOUTCOMES.111.000054 Daniel Kramer, Kevin Kennedy, Peter Noseworthy, Alfred Buxton, Mark Josephson, Sharon-Lise Normand, John Spertus, Peter Zimetbaum, Matthew Reynolds, and Susan Mitchell. 2013. “[Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results from the NCDR](/publications/characteristics-and-outcomes-patients-receiving-new-and-replacement-implantable)”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 488-97. doi:10.1161/CIRCOUTCOMES.111.000054 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Little is known about the clinical features, procedural risks, or survival of patients receiving replacement versus new implantable cardioverter-defibrillators (ICDs).METHODS AND RESULTS: Entries in the National Cardiovascular Data Registry... Jason Wasfy, Kenneth Rosenfield, Katya Zelevinsky, Rahul Sakhuja, Ann Lovett, John Spertus, Neil Wimmer, Laura Mauri, Sharon-Lise Normand, and Robert Yeh. 2013. “[A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention](/publications/prediction-model-identify-patients-high-risk-30-day-readmission-after)”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 429-35. doi:10.1161/CIRCOUTCOMES.111.000093 Jason Wasfy, Kenneth Rosenfield, Katya Zelevinsky, Rahul Sakhuja, Ann Lovett, John Spertus, Neil Wimmer, Laura Mauri, Sharon-Lise Normand, and Robert Yeh. 2013. “[A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention](/publications/prediction-model-identify-patients-high-risk-30-day-readmission-after)”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 429-35. doi:10.1161/CIRCOUTCOMES.111.000093 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: The Affordable Care Act creates financial incentives for hospitals to minimize readmissions shortly after discharge for several conditions, with percutaneous coronary intervention (PCI) to be a target in 2015. We aimed to develop and validate... Alice Jacobs, Sharon-Lise Normand, Joseph Massaro, Donald Cutlip, Joseph Carrozza, Anthony Marks, Nancy Murphy, Iyah Romm, Madeleine Biondolillo, and Laura Mauri. 2013. “[Nonemergency PCI at Hospitals With or Without On-Site Cardiac Surgery](/publications/nonemergency-pci-hospitals-or-without-site-cardiac-surgery)”. N Engl J Med, 368, 16, Pp. 1498-508. doi:10.1056/NEJMoa1300610 Alice Jacobs, Sharon-Lise Normand, Joseph Massaro, Donald Cutlip, Joseph Carrozza, Anthony Marks, Nancy Murphy, Iyah Romm, Madeleine Biondolillo, and Laura Mauri. 2013. “[Nonemergency PCI at Hospitals With or Without On-Site Cardiac Surgery](/publications/nonemergency-pci-hospitals-or-without-site-cardiac-surgery)”. N Engl J Med, 368, 16, Pp. 1498-508. doi:10.1056/NEJMoa1300610 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Emergency surgery has become a rare event after percutaneous coronary intervention (PCI). Whether having cardiac-surgery services available on-site is essential for ensuring the best possible outcomes during and after PCI remains uncertain... ### 2014 Jason Wasfy, Jordan Strom, Cashel O’Brien, Adrian Zai, Jennifer Luttrell, Kevin Kennedy, John Spertus, Katya Zelevinsky, Sharon-Lise Normand, Laura Mauri, and Robert Yeh. 2014. “[Causes of Short-Term Readmission After Percutaneous Coronary Intervention](/publications/causes-short-term-readmission-after-percutaneous-coronary-intervention)”. Circ Cardiovasc Interv, 7, 1, Pp. 97-103. doi:10.1161/CIRCINTERVENTIONS.113.000988 Jason Wasfy, Jordan Strom, Cashel O’Brien, Adrian Zai, Jennifer Luttrell, Kevin Kennedy, John Spertus, Katya Zelevinsky, Sharon-Lise Normand, Laura Mauri, and Robert Yeh. 2014. “[Causes of Short-Term Readmission After Percutaneous Coronary Intervention](/publications/causes-short-term-readmission-after-percutaneous-coronary-intervention)”. Circ Cardiovasc Interv, 7, 1, Pp. 97-103. doi:10.1161/CIRCINTERVENTIONS.113.000988 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Rehospitalization within 30 days after an admission for percutaneous coronary intervention (PCI) is common, costly, and a future target for Medicare penalties. Causes of readmission after PCI are largely unknown.METHODS AND RESULTS: To... Robert Yeh, Samip Vasaiwala, Daniel Forman, Treacy Silbaugh, Katya Zelevinski, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2014. “[Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly](/publications/instrumental-variable-analysis-compare-effectiveness-stents-extremely-elderly)”. Circ Cardiovasc Qual Outcomes, 7, 1, Pp. 118-24. doi:10.1161/CIRCOUTCOMES.113.000476 Robert Yeh, Samip Vasaiwala, Daniel Forman, Treacy Silbaugh, Katya Zelevinski, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2014. “[Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly](/publications/instrumental-variable-analysis-compare-effectiveness-stents-extremely-elderly)”. Circ Cardiovasc Qual Outcomes, 7, 1, Pp. 118-24. doi:10.1161/CIRCOUTCOMES.113.000476 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Evaluating novel therapies is challenging in the extremely elderly. Instrumental variable methods identify variables associated with treatment allocation to perform adjusted comparisons that may overcome limitations of more traditional... Michelle Albert, John Ayanian, Treacy Silbaugh, Ann Lovett, Fred Resnic, Aryana Jacobs, and Sharon-Lise Normand. 2014. “[Early Results of Massachusetts Healthcare Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care](/publications/early-results-massachusetts-healthcare-reform-racial-ethnic-and-socioeconomic)”. Circulation, 129, 24, Pp. 2528-38. doi:10.1161/CIRCULATIONAHA.113.005231 Michelle Albert, John Ayanian, Treacy Silbaugh, Ann Lovett, Fred Resnic, Aryana Jacobs, and Sharon-Lise Normand. 2014. “[Early Results of Massachusetts Healthcare Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care](/publications/early-results-massachusetts-healthcare-reform-racial-ethnic-and-socioeconomic)”. Circulation, 129, 24, Pp. 2528-38. doi:10.1161/CIRCULATIONAHA.113.005231 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Insured adults receive invasive cardiovascular procedures more frequently than uninsured adults. We examined the impact of healthcare reform in Massachusetts on use of coronary revascularization procedures and in-hospital and 1-year mortality... ### 2017 Abdallah Alameddine, Paul Visintainer, Sharon-Lise Normand, Robert Wolf, and Yvonne Alameddine. 2017. “[Cancer Rates in Adults After Cardiac Interventions: A Preliminary Observational Report](/publications/cancer-rates-adults-after-cardiac-interventions-preliminary-observational)”. Am J Clin Oncol, 40, 2, Pp. 122-24. doi:10.1097/COC.0000000000000120 Abdallah Alameddine, Paul Visintainer, Sharon-Lise Normand, Robert Wolf, and Yvonne Alameddine. 2017. “[Cancer Rates in Adults After Cardiac Interventions: A Preliminary Observational Report](/publications/cancer-rates-adults-after-cardiac-interventions-preliminary-observational)”. Am J Clin Oncol, 40, 2, Pp. 122-24. doi:10.1097/COC.0000000000000120 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: The postprocedural state after cardiac revascularization interventions is characterized by intense inflammation and activation of inflammatory cytokines due to myonecrosis and ischemia/reperfusion injury. Involvement of similar processes also... ### 2015 Sripal Bangalore, Treacy Silbaugh, Sharon-Lise Normand, Ann Lovett, Frederick Welt, and Frederic Resnic. 2015. “[Drug-Eluting Stents versus Bare Metal Stents Prior to Noncardiac Surgery](/publications/drug-eluting-stents-versus-bare-metal-stents-prior-noncardiac-surgery)”. Catheter Cardiovasc Interv, 85, 4, Pp. 533-41. doi:10.1002/ccd.25617 Sripal Bangalore, Treacy Silbaugh, Sharon-Lise Normand, Ann Lovett, Frederick Welt, and Frederic Resnic. 2015. “[Drug-Eluting Stents versus Bare Metal Stents Prior to Noncardiac Surgery](/publications/drug-eluting-stents-versus-bare-metal-stents-prior-noncardiac-surgery)”. Catheter Cardiovasc Interv, 85, 4, Pp. 533-41. doi:10.1002/ccd.25617 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: The safety of drug-eluting stents (DES) vs. bare metal stents (BMS) in the perioperative setting, a heightened state of inflammation and thrombosis is not well defined.METHODS: All adults undergoing noncardiac surgical (NCS) procedures within... ### 2016 Jacob Spertus V, Sharon-Lise T Normand, Robert Wolf, Matt Cioffi, Ann Lovett, and Sherri Rose. 2016. “[Assessing Hospital Performance After Percutaneous Coronary Intervention Using Big Data.](/publication/assessing-hospital-performance-after-percutaneous-coronary-intervention-using-big-data)”. Circulation. Cardiovascular Quality and Outcomes, 9, 6, Pp. 659-69. doi:10.1161/CIRCOUTCOMES.116.002826 Jacob Spertus V, Sharon-Lise T Normand, Robert Wolf, Matt Cioffi, Ann Lovett, and Sherri Rose. 2016. “[Assessing Hospital Performance After Percutaneous Coronary Intervention Using Big Data.](/publication/assessing-hospital-performance-after-percutaneous-coronary-intervention-using-big-data)”. Circulation. Cardiovascular Quality and Outcomes, 9, 6, Pp. 659-69. doi:10.1161/CIRCOUTCOMES.116.002826 - add\_circle do\_not\_disturb\_on Abstract BACKGROUND: Although risk adjustment remains a cornerstone for comparing outcomes across hospitals, optimal strategies continue to evolve in the presence of many confounders. We compared conventional regression-based model to approaches particularly... ### 2003 David M Shahian and Sharon-Lise T Normand. 2003. “[The Volume-Outcome Relationship: From Luft to Leapfrog.](/publication/volume-outcome-relationship-luft-leapfrog)”. The Annals of Thoracic Surgery, 75, 3, Pp. 1048-58 David M Shahian and Sharon-Lise T Normand. 2003. “[The Volume-Outcome Relationship: From Luft to Leapfrog.](/publication/volume-outcome-relationship-luft-leapfrog)”. The Annals of Thoracic Surgery, 75, 3, Pp. 1048-58 - add\_circle do\_not\_disturb\_on Abstract Numerous reports have documented a volume-outcome relationship for complex medical and surgical care, although many such studies are compromised by the use of discharge abstract data, inadequate risk adjustment, and problematic statistical methodology... ### 2001 D M Shahian, S L Normand, D F Torchiana, S M Lewis, J O Pastore, R E Kuntz, and P I Dreyer. 2001. “[Cardiac Surgery Report Cards: Comprehensive Review and Statistical Critique.](/publication/cardiac-surgery-report-cards-comprehensive-review-and-statistical-critique)”. The Annals of Thoracic Surgery, 72, 6, Pp. 2155-68 D M Shahian, S L Normand, D F Torchiana, S M Lewis, J O Pastore, R E Kuntz, and P I Dreyer. 2001. “[Cardiac Surgery Report Cards: Comprehensive Review and Statistical Critique.](/publication/cardiac-surgery-report-cards-comprehensive-review-and-statistical-critique)”. The Annals of Thoracic Surgery, 72, 6, Pp. 2155-68 - add\_circle do\_not\_disturb\_on Abstract Public report cards and confidential, collaborative peer education represent distinctly different approaches to cardiac surgery quality assessment and improvement. This review discusses the controversies regarding their methodology and relative...